title: Are Prescription Opioids Driving the Opioid Crisis? Assumptions vs Facts.
abstract: Sharp increases in opioid prescriptions, and associated increases in overdose deaths in the 2000s, evoked widespread calls to change perceptions of opioid analgesics. Medical literature discussions of opioid analgesics began emphasizing patient and public health hazards. Repetitive exposure to this information may influence physician assumptions. While highly consequential to patients with pain whose function and quality of life may benefit from opioid analgesics, current assumptions about prescription opioid analgesics, including their role in the ongoing opioid overdose epidemic, have not been scrutinized.
  
  
  
  Information was obtained by searching PubMed, governmental agency websites, and conference proceedings.
  
  
  
  Opioid analgesic prescribing and associated overdose deaths both peaked around 2011 and are in long-term decline; the sharp overdose increase recorded in 2014 was driven by illicit fentanyl and heroin. Nonmethadone prescription opioid analgesic deaths, in the absence of co-ingested benzodiazepines, alcohol, or other central nervous system/respiratory depressants, are infrequent. Within five years of initial prescription opioid misuse, 3.6% initiate heroin use. The United States consumes 80% of the world opioid supply, but opioid access is nonexistent for 80% and severely restricted for 4.1% of the global population.
  
  
  
  Many current assumptions about opioid analgesics are ill-founded. Illicit fentanyl and heroin, not opioid prescribing, now fuel the current opioid overdose epidemic. National discussion has often neglected the potentially devastating effects of uncontrolled chronic pain. Opioid analgesic prescribing and related overdoses are in decline, at great cost to patients with pain who have benefited or may benefit from, but cannot access, opioid analgesic therapy.
authors.affiliation: Medical and Bio-behavioral Communications Global, Inc; Private Practice, Consulting Psychology.
authors.forename: Mark Edmund
authors.initials: ME
authors.lastname: Rose
mesh_terms: D000701:Analgesics, Opioid / Q000627:therapeutic use*; D062787:Drug Overdose / Q000453:epidemiology* / Q000209:etiology*; D005283:Fentanyl / Q000009:adverse effects; D003932:Heroin / Q000009:adverse effects; D006801:Humans; D009293:Opioid-Related Disorders / Q000453:epidemiology*; D055553:Prescription Drugs; D019966:Substance-Related Disorders / Q000453:epidemiology*
chemical_list: D000701:Analgesics, Opioid; D055553:Prescription Drugs; D003932:Heroin; D005283:Fentanyl